Quick Summary: Two Different Approaches
SkinVision and ScanSkinAI both offer AI-powered skin analysis, but they serve different market segments and use cases. Understanding these differences is essential for making the right procurement decision.
SkinVision is a well-known consumer skin cancer app with CE Class IIa medical device classification in Europe. It focuses specifically on melanoma and non-melanoma skin cancer risk assessment, making it suitable for EU-regulated cancer screening use cases.
ScanSkinAI is a broader AI health screening platform designed specifically for B2B deployment, covering skin (31+ conditions), oral health, and heart risk assessment. It offers enterprise-grade integration options (SSO, API, white-label), ISO 27001 and ISO 13485 certifications, and validated accuracy across all Fitzpatrick skin types (I–VI).
The right choice depends on your specific requirements: SkinVision if you need CE-marked cancer-only screening for strict EU regulatory compliance; ScanSkinAI if you need a comprehensive, multi-category wellness tool with enterprise integration for diverse workforce deployment.
Feature-by-Feature Comparison Table
This comparison is based on publicly available information as of March 2026. We've aimed to be fair and factual — noting areas where SkinVision has advantages alongside ScanSkinAI's strengths:
| Feature | ScanSkinAI | SkinVision |
|---|---|---|
| Conditions Detected | 31+ (skin, oral, heart) | Skin cancer only |
| Fitzpatrick Validation | I–VI (all skin tones) | I–III primarily |
| ISO 27001:2022 | Yes | No |
| ISO 13485 | Yes | No |
| Quality Framework | UKCA Class I-aligned, ISO 27001, ISO 13485 | CE Class IIa medical device |
| White-Label Option | Yes (iframe/WebView) | Limited |
| SSO Integration | SAML 2.0 / OAuth 2.0 | No |
| REST API | Yes (JWT-secured) | No public API |
| Expert Dermatologist Review | 8h / 24h / 48h tiers | Not included |
| Chronic Condition Tracking | Yes (eczema, psoriasis, acne) | No |
| Wound Care Assessment | Yes | No |
| Oral & Heart Screening | Yes | No |
| Clinical Triage Levels | 4-level system | 3-level (low/medium/high) |
| Per-Employee Pricing | Yes (PEPM) | Per-scan or subscription |
When to Choose ScanSkinAI for Your Organisation
ScanSkinAI is the stronger choice when your organisation requires broad health screening coverage, enterprise integration, or deployment across diverse populations:
- You need multi-category screening (skin + oral + heart) consolidated in a single platform to reduce vendor complexity
- You require enterprise integration capabilities: SSO, REST API, white-label embedding, or WebView deployment
- Your workforce or policyholder base is diverse and you need validated accuracy across all skin tones (Fitzpatrick I–VI)
- You want built-in dermatologist review with configurable turnaround options (8h express / 24h / 48h standard)
- You need chronic condition tracking for ongoing management of eczema, psoriasis, and acne across your population
- ISO 27001 and ISO 13485 certifications are required by your compliance, procurement, or governance team
- You want per-employee-per-month pricing with no per-scan usage caps that could create unexpected costs
When SkinVision Might Be More Suitable
In fairness, there are specific scenarios where SkinVision's positioning may be advantageous:
- You specifically require CE Class IIa medical device classification for EU regulatory compliance in cancer screening
- Your use case is strictly limited to skin cancer risk assessment (not broader dermatology, chronic conditions, or wellness)
- You're looking for a consumer-facing app without enterprise integration requirements and don't need SSO or API access
Key Differentiators for B2B Decision-Makers
Integration Architecture
ScanSkinAI's multi-tenant architecture supports four deployment models (direct app, WebView, SSO, API) with JWT-secured webhooks and environment-separated sandbox/production deployments. SkinVision primarily operates as a standalone consumer app without documented B2B integration endpoints.
Skin Tone Equity
ScanSkinAI is built with Fitzpatrick I–VI stratification across its training and audit pipeline, designed for equitable analytical performance across diverse populations. Detailed methodology and validation work is published on the Evidence Base page. This is increasingly important for both regulatory compliance (EU AI Act) and ethical deployment across global workforces.
Breadth of Conditions
SkinVision focuses exclusively on skin cancer risk assessment. ScanSkinAI screens for 31+ dermatological conditions plus oral health and heart risk — making it a comprehensive wellness tool rather than a single-condition screener. For employers and insurers, this breadth translates to higher engagement and broader cost savings.
Frequently Asked Questions
See ScanSkinAI in Action
Explore deployment options, certifications, pilot data, and enterprise features.